Business News›Markets›Stocks›Earnings›Sun Pharma Q1 Results: PAT dips 2% YoY to Rs 2,023 cr on one-time expense
Sun Pharma Q1 Results: PAT dips 2% YoY to Rs 2,023 cr on one-time expense
Sun Pharmaceutical on Thursday reported a nearly 2% year-on-year (YoY) drop in consolidated net profit for the quarter ended June 2023 to Rs 2,023 crore. Revenue from operations increased nearly 11% on year to Rs 11,941 crore. The fall in the bottomline was partly due to certain one-time charges totalling Rs 323 crore.
Read more on
02:46- 04:19
- 02:55
- 05:13
- 02:06
- 03:27
- 03:24
- 02:24
- 01:55
- 01:22
- 04:50
- 03:01
- 04:00
- 04:26
- 03:37
- 01:48
- 03:57
- 01:19
- 03:00
- 03:07
- 04:14
- 01:56
- 04:46
- 02:50
- 02:27
- 01:29
- 08:47
- 04:14
- 05:26
- 03:55
- 00:41
- 01:08
- 01:31
- 01:41
- 01:08
- 01:42
- 02:43
- 00:43
- 01:53
- 01:31
